权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston

宿主遗传学、生命早期微生物组和儿童哮喘：MARC-43 波士顿

基本信息

批准号：
10742124
负责人：
CARLOS A. CAMARGO
金额：
$ 87.48万
依托单位：
MASSACHUSETTS GENERAL HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-09-21 至 2025-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10742124
关键词：
Affect Age Airway Disease Area Asthma Bacteroides Biological Boston CCL7 gene Child Child Development Child Health Childhood Childhood Asthma Clinical Clinical Data Complement 4b Data Data Element Development Disease Enrollment Environment Environmental Exposure Epidemiologic Methods Epidemiology Ethnic Origin Ethnic Population Extrinsic asthma Funding Future Genetic Genetic Variation Genome Genotype Glucuronates Goals Health International Intervention Knowledge Leadership Learning Life Mendelian randomization Microbe Moraxella Nose Obesity Outcome Participant Pathogenesis Pathway interactions Pediatric cohort Phenotype Positioning Attribute Protocols documentation Public Health Pulmonary Function Test/Forced Expiratory Volume 1 Race Regulation Reporting Research Research Personnel Resources Risk Role Single Nucleotide Polymorphism Site Statistical Methods Streptococcus TLR4 gene Testing United States National Institutes of Health Work cohort evidence base genome wide association study genomic locus gut microbiome innovation insight microbiome microbiome composition microbiome research nasal microbiome neurodevelopment neuron development novel obesity development obesity in children obesity-associated asthma participant enrollment prevent preventive intervention programs pulmonary function respiratory microbiome social stressor statistics whole genome working group

项目摘要

Project Abstract Recent studies report probabilistic associations between the early-life microbiome and various child health outcomes (e.g., obesity, asthma), suggesting potential insights into pathogenesis and subsequent, targeted development of preventive interventions. However, the causal role of the early-life microbiome on child health remains unclear. Our preliminary work has applied state-of-art statistical genetics and causal inference approaches to large genetics and microbiome data in our ECHO-supported cohorts, demonstrating: 1) host genetic loci for airway Streptococcus across racial/ethnic populations, 2) host genetic loci for gut microbiome and significantly enriched biological pathways (e.g., regulation of neuron development, glucuronate interconversions), and 3) relationship of gut Bacteroides with obesity and asthma risk. Our central hypothesis is that the genetically driven gut and upper airway microbiome in the first two years of life has a causal role in the development of child health outcomes, such as obesity and airway outcomes. This UG3/UH3 project will test this innovative hypothesis by applying the latest statistical genetics and epidemiological methods—e.g., microbiome genome-wide association study (mGWAS)— to large ECHO genetics, microbiome, and extensive clinical and environmental data. By using ECHO core data elements, Aim 1 will generate mGWAS summary statistics to enable researchers to examine the causal role of the early-life microbiome on child health outcomes. For example, by using the mGWAS and Mendelian randomization approaches, we will determine the causal role of the gut and nasal airway microbiome (during age 0-1.9 years) in the risk of developing childhood obesity. By using specialized airway outcome data, Aim 2 will determine whether the genetically driven gut and nasal microbiome has a causal effect on the development of asthma (and its major phenotypes) and on lower lung function in later childhood. Aim 3 will maximize the retention of existing ECHO Cohort Protocol (ECP) participants, with emphasis on diversity, and implement the ECP with high fidelity. (To date, in MARC-43 Boston participants, ECP retention is 100%, with >80% data completeness.) The proposed project will serve as a national research resource for examining the causal role of early-life microbiome in various childhood health outcomes. Furthermore, the project will provide a robust evidence base for the future development of targeted microbiome interventions to prevent childhood obesity and asthma. The investigators are NIH-funded researchers with international expertise in all relevant fields (e.g., epidemiology, statistical genetics, microbiome, childhood obesity, asthma). The project matches well with the goals of the ECHO Program.

项目摘要